
Jeplus.in
Purchase All Medicines.Get 10% Offer

Express Pharma
The partnership integrates PayU’s payment infrastructure with Marg ERP to enable digital collections and automated reconciliation for distributors, retailers and MSMEs The post PayU partners with Marg ERP to streamline digital payments for pharma distributors appeared first on Express Pharma.

Pharma Tech
Alongside Alkeus, companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargardt market with no approved drugs.

Pharma Tech
Following the discontinuation of CT-95, Context will now focus on the two other BiTEs in its pipeline, CTIM-76 and CT-202.

Pharma Tech
The approval means mFlusiva becomes the first mRNA-based vaccine to be authorised on the US market for flu prevention.

Pharma Tech
Evotec and Odyssey Therapeutics have announced a strategic AI-enabled R&D partnership to explore new treatments for autoimmune and inflammatory diseases.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
ET Pharma
Aug 8, 2026, 4:49 PM
Over the past month, most segments within the acute therapy market reported a positive uptick, in line with the seasonal disease pattern. Antihistamines, which are used to treat allergies such as sneezing and runny nose hit a record reaching their highest level since January 2022.
ET Pharma
Aug 8, 2026, 11:29 AM
The revival remains concentrated among a few companies, with 11 of the 33 brands accounting for 80 per cent of total sales volume. Leading the charge was Dr Reddy’s Obeda, whose sales more than doubled to 1.15 lakh units from 55,000 units in June.
ET Pharma
Aug 8, 2026, 2:30 AM
Under the agreement, Gland Pharma will build a dedicated sterile manufacturing suite at its JNPC facility in Visakhapatnam to support Neuland’s rising requirements for sterile APIs used in microparticle depot products and other complex sterile ingredients.
ET Pharma
Aug 7, 2026, 2:54 PM
The Mumbai-based drugmaker expects its new biosimilar launches to generate over $100 million in sales over the next three years, while its 505(b)(2) portfolio is expected to offset the anticipated moderation in US sales. In India, the company has outlined an ambitious 10-year roadmap to transform its portfolio, with innovative medicines targeted to account for 30 per cent of the product mix, driven by in-house R&D and licensing push.
PharmaShots
Aug 7, 2026, 12:30 PM
Shots: Ref: CA newswire |  Image: Regeneron |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Health Canada Approves Regeneron’s Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma appeared first on PharmaShots.
PharmaShots
Aug 7, 2026, 11:30 AM
Shots: Ref: Businesswire |  Image: Merck |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post US FDA Accepts sBLA for Merck’s Enflonsia to Expand RSV LRTD Prevention Indication appeared first on PharmaShots.
News
Google News
Aug 9, 2026, 3:34 AM
Antitrust Challenge to GLP-1 Distribution Deals Falls Short in Federal Court  PYMNTS.com
Google News
Aug 9, 2026, 3:34 AM
Corporate Actions This Week: Indus Towers, PTC India, Gland Pharma, HAL, HPCL, REC | Full List  NDTV Profit
Google News
Aug 9, 2026, 3:22 AM
Has Ultragenyx Pharmaceutical (RARE) Fallen Far Enough To Avoid Overvaluation?  Yahoo Finance
Google News
Aug 9, 2026, 1:41 AM
Pharmaceutical CXOs Stocks Surge Sharply Across the Board: Real Industry Recovery or Hype-Driven Rally?  36 Kr
Google News
Aug 9, 2026, 1:11 AM
Santen Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next  simplywall.st
Google News
Aug 9, 2026, 1:10 AM
Vietnam’s pharmaceutical market hits $7 bln mark  Vietnam Economic Times
Google News
Aug 8, 2026, 11:57 PM
Astellas Pharma Inc. Just Recorded A 55% EPS Beat: Here's What Analysts Are Forecasting Next  simplywall.st
Google News
Aug 8, 2026, 7:45 PM
"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics  MarketScale
Google News
Aug 8, 2026, 6:46 PM
Karl Fischer Titration Reagents Market to Reach Index 170 by 2035 on Pharma QC Demand  IndexBox
Sponsored placement

Purchase All Medicines.Get 10% Offer